Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Michael Busch, MD, PhD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentLaboratory Medicine
    Address270 Masonic
    San Francisco CA 94143

       Biography 
       Education and Training
      Institution Degree School or Department Year
      University of California, San FranciscoResidency School of Medicine - Laboratory Medicine

       ORNG Applications 
       Websites
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Kassanjee R, Pilcher CD, Keating SM, Facente SN, McKinney E, Price MA, Martin JN, Little S, Hecht FM, Kallas EG, Welte A, Busch MP, Murphy G. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS. 2014 Oct 23; 28(16):2439-49.
        View in: PubMed
      2. Henrich TJ, Hanhauser E, Marty FM, Sirignano MN, Keating S, Lee TH, Robles YP, Davis BT, Li JZ, Heisey A, Hill AL, Busch MP, Armand P, Soiffer RJ, Altfeld M, Kuritzkes DR. Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation: Report of 2 Cases. Ann Intern Med. 2014 Sep 2; 161(5):319-27.
        View in: PubMed
      3. Levin AE, Williamson PC, Erwin JL, Cyrus S, Bloch EM, Shaz BH, Kessler D, Telford SR, Krause PJ, Wormser GP, Ni X, Wang H, Krueger NX, Caglioti S, Busch MP. Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. Transfusion. 2014 Sep; 54(9):2237-44.
        View in: PubMed
      4. Al-Hajjar SH, Frayha HH, Al-Hazmi M, Batawi R, McIntosh K, Sax PE, Al-Thawadi S, Al-Jumaah S, Busch MP, Hanhauser E, Kuritzkes DR, Li JZ, Henrich TJ. Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion. AIDS. 2014 Jun 19; 28(10):1539-41.
        View in: PubMed
      5. Pessôa R, Carneiro Proietti AB, Busch MP, Sanabani SS. Identification of a Novel HIV-1 Circulating Recombinant Form (CRF72_BF1) in Deep Sequencing Data from Blood Donors in Southeastern Brazil. Genome Announc. 2014; 2(3).
        View in: PubMed
      6. Asher AK, Santos GM, Evans J, Dokubo EK, Lee TH, Martin JN, Deeks SG, Tobler LH, Busch M, Hunt PW, Page K. A closer look at hepatitis C clearance in HIV controllers: a response. AIDS. 2014 May 15; 28(8):1241-2.
        View in: PubMed
      7. Stock PG, Barin B, Hatano H, Rogers RL, Roland ME, Lee TH, Busch M, Deeks SG. Reduction of HIV Persistence Following Transplantation in HIV-Infected Kidney Transplant Recipients. Am J Transplant. 2014 May; 14(5):1136-41.
        View in: PubMed
      8. Lanteri MC, Diamond MS, Law JP, Chew GM, Wu S, Inglis HC, Wong D, Busch MP, Norris PJ, Ndhlovu LC. Increased frequency of tim-3 expressing T cells is associated with symptomatic west nile virus infection. PLoS One. 2014; 9(3):e92134.
        View in: PubMed
      9. Landay A, Golub ET, Desai S, Zhang J, Winkelman V, Anastos K, Durkin H, Young M, Villacres MC, Greenblatt RM, Norris PJ, Busch MP. HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients. AIDS. 2014 Mar 13; 28(5):739-43.
        View in: PubMed
      10. Sanchez AM, DeMarco CT, Hora B, Keinonen S, Chen Y, Brinkley C, Stone M, Tobler L, Keating S, Schito M, Busch MP, Gao F, Denny TN. Development of a contemporary globally diverse HIV viral panel by the EQAPOL program. J Immunol Methods. 2014 Jul; 409:117-30.
        View in: PubMed
      11. Penezina O, Krueger NX, Rodriguez-Chavez IR, Busch MP, Hural J, Kim JH, O'Connell RJ, Hunter E, Aboud S, Higgins K, Kovalenko V, Clapham D, Crane D, Levin AE. Performance of a Redesigned HIV Selectest Enzyme-Linked Immunosorbent Assay Optimized To Minimize Vaccine-Induced Seropositivity in HIV Vaccine Trial Participants. Clin Vaccine Immunol. 2014 Mar; 21(3):391-8.
        View in: PubMed
      12. Bakkour S, Baker CA, Tarantal AF, Wen L, Busch MP, Lee TH, McCune JM. Analysis of maternal microchimerism in rhesus monkeys (Macaca mulatta) using real-time quantitative PCR amplification of MHC polymorphisms. Chimerism. 2014 Jan 1; 5(1):6-15.
        View in: PubMed
      13. Vahidnia F, Hirschler NV, Agapova M, Chinn A, Busch MP, Custer B. Cancer Incidence and Mortality in a Cohort of US Blood Donors: A 20-Year Study. J Cancer Epidemiol. 2013; 2013:814842.
        View in: PubMed
      14. Pilcher CD, Louie B, Facente S, Keating S, Hackett J, Vallari A, Hall C, Dowling T, Busch MP, Klausner JD, Hecht FM, Liska S, Pandori MW. Performance of Rapid Point-of-Care and Laboratory Tests for Acute and Established HIV Infection in San Francisco. PLoS One. 2013; 8(12):e80629.
        View in: PubMed
      15. Deng X, Sabino EC, Cunha-Neto E, Ribeiro AL, Ianni B, Mady C, Busch MP, Seielstad M. Genome Wide Association Study (GWAS) of Chagas Cardiomyopathy in Trypanosoma cruzi Seropositive Subjects. PLoS One. 2013; 8(11):e79629.
        View in: PubMed
      16. Asher AK, Santos GM, Evans J, Dokubo EK, Lee TH, Martin JN, Deeks SG, Tobler LH, Busch M, Hunt PW, Page K. Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers. AIDS. 2013 Nov 13; 27(17):2691-6.
        View in: PubMed
      17. Kleinman S, Busch MP, Murphy EL, Shan H, Ness P, Glynn SA. The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes. Transfusion. 2014 Mar; 54(3 Pt 2):942-55.
        View in: PubMed
      18. Keating SM, Heitman JD, Wu S, Deng X, Stramer SL, Kuhns MC, Mullen C, Norris PJ, Busch MP. Cytokine and chemokine responses in the acute phase of hepatitis B virus replication in naive and previously vaccinated blood and plasma donors. J Infect Dis. 2014 Mar; 209(6):845-54.
        View in: PubMed
      19. Hatano H, Yukl SA, Ferre AL, Graf EH, Somsouk M, Sinclair E, Abdel-Mohsen M, Liegler T, Harvill K, Hoh R, Palmer S, Bacchetti P, Hunt PW, Martin JN, McCune JM, Tracy RP, Busch MP, O'Doherty U, Shacklett BL, Wong JK, Deeks SG. Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog. 2013; 9(10):e1003691.
        View in: PubMed
      20. Busch MP, Ness PM. First "themed issue" of Transfusion on thirty years of progress in blood safety since recognition of transfusion-associated AIDS. Transfusion. 2013 Oct; 53(10 Pt 2):2357-8.
        View in: PubMed
      21. Busch MP, Ness PM. First "themed issue" of TRANSFUSION on thirty years of progress in blood safety since recognition of transfusion-associated AIDS. Transfusion. 2013 Oct; 53(10):2120-1.
        View in: PubMed
      22. Busch MP, Ness PM. Herbert Asa Perkins, MD. Transfusion. 2013 Oct; 53(10):2355-6.
        View in: PubMed
      23. Sabino EC, Ribeiro AL, Salemi VM, Ianni BM, Nastari L, Fernandes F, Di Lorenzo Oliveira C, Antunes AP, Menezes MM, Patavino GM, Capuani L, de Almeida-Neto C, Sachdev V, Carrick DM, Wright D, Kavounis K, Gonzalez TT, Custer B, Busch MP, Murphy EL, Carneiro-Proietti AB. Response to letters regarding article, "Ten-year incidence of Chagas cardiomyopathy among asymptomatic, Trypanosoma cruzi-seropositive former blood donors". Circulation. 2013 Aug 27; 128(9):e137-8.
        View in: PubMed
      24. Jain V, Hartogensis W, Bacchetti P, Hunt PW, Hatano H, Sinclair E, Epling L, Lee TH, Busch MP, McCune JM, Pilcher CD, Hecht FM, Deeks SG. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis. 2013 Oct 15; 208(8):1202-11.
        View in: PubMed
      25. Alencar CS, Sabino EC, Carvalho SM, Leao SC, Carneiro-Proietti AB, Capuani L, Oliveira CL, Carrick D, Birch RJ, Gonçalez TT, Keating S, Swanson PA, Hackett J, Busch MP. HIV genotypes and primary drug resistance among HIV-seropositive blood donors in Brazil: role of infected blood donors as sentinel populations for molecular surveillance of HIV. J Acquir Immune Defic Syndr. 2013 Jul 1; 63(3):387-92.
        View in: PubMed
      26. Jackman RP, Deng X, Bolgiano D, Utter GH, Schechterly C, Lebedeva M, Operskalski E, Luban NL, Alter H, Busch MP, Slichter SJ, Norris PJ. Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response. Transfusion. 2014 Mar; 54(3):672-80.
        View in: PubMed
      27. Fleck S, Bautista G, Keating SM, Lee TH, Keller RL, Moon-Grady AJ, Gonzales K, Norris PJ, Busch MP, Kim CJ, Romero R, Lee H, Miniati D, MacKenzie TC. Fetal production of growth factors and inflammatory mediators predicts pulmonary hypertension in congenital diaphragmatic hernia. Pediatr Res. 2013 Sep; 74(3):290-8.
        View in: PubMed
      28. Yukl SA, Boritz E, Busch M, Bentsen C, Chun TW, Douek D, Eisele E, Haase A, Ho YC, Hütter G, Justement JS, Keating S, Lee TH, Li P, Murray D, Palmer S, Pilcher C, Pillai S, Price RW, Rothenberger M, Schacker T, Siliciano J, Siliciano R, Sinclair E, Strain M, Wong J, Richman D, Deeks SG. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. PLoS Pathog. 2013; 9(5):e1003347.
        View in: PubMed
      29. Henrich TJ, Hu Z, Li JZ, Sciaranghella G, Busch MP, Keating SM, Gallien S, Lin NH, Giguel FF, Lavoie L, Ho VT, Armand P, Soiffer RJ, Sagar M, Lacasce AS, Kuritzkes DR. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J Infect Dis. 2013 Jun 1; 207(11):1694-702.
        View in: PubMed
      30. Ribeiro AL, Sabino EC, Marcolino MS, Salemi VM, Ianni BM, Fernandes F, Nastari L, Antunes A, Menezes M, Oliveira CD, Sachdev V, Carrick DM, Busch MP, Murphy EL. Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors. PLoS Negl Trop Dis. 2013; 7(2):e2078.
        View in: PubMed
      31. Mast AE, Schlumpf KS, Wright DJ, Johnson B, Glynn SA, Busch MP, Olbina G, Westerman M, Nemeth E, Ganz T. Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy. Haematologica. 2013 Aug; 98(8):1324-30.
        View in: PubMed
      32. Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Tobler LH, Busch MP, Alexander G, Rosen HR, Gao X, Abdel-Hamid M, Apps R, Carrington M, Thomas DL. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med. 2013 Feb 19; 158(4):235-45.
        View in: PubMed
      33. Sabino EC, Ribeiro AL, Salemi VM, Di Lorenzo Oliveira C, Antunes AP, Menezes MM, Ianni BM, Nastari L, Fernandes F, Patavino GM, Sachdev V, Capuani L, de Almeida-Neto C, Carrick DM, Wright D, Kavounis K, Goncalez TT, Carneiro-Proietti AB, Custer B, Busch MP, Murphy EL. Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors. Circulation. 2013 Mar 12; 127(10):1105-15.
        View in: PubMed
      34. Terrault NA, Dodge JL, Murphy EL, Tavis JE, Kiss A, Levin TR, Gish RG, Busch MP, Reingold AL, Alter MJ. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013 Mar; 57(3):881-9.
        View in: PubMed
      35. Jackman RP, Deng X, Bolgiano D, Lebedeva M, Heitman JW, Busch MP, Slichter SJ, Norris PJ. Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants. Blood. 2013 Apr 18; 121(16):3261-6; quiz 3299.
        View in: PubMed
      36. Bloch EM, Lee TH, Krause PJ, Telford SR, Montalvo L, Chafets D, Usmani-Brown S, Lepore TJ, Busch MP. Development of a real-time polymerase chain reaction assay for sensitive detection and quantitation of Babesia microti infection. Transfusion. 2013 Oct; 53(10):2299-306.
        View in: PubMed
      37. Selvarajah S, Busch MP. Transfusion transmission of HCV, a long but successful road map to safety. Antivir Ther. 2012; 17(7 Pt B):1423-9.
        View in: PubMed
      38. Ramos HJ, Lanteri MC, Blahnik G, Negash A, Suthar MS, Brassil MM, Sodhi K, Treuting PM, Busch MP, Norris PJ, Gale M. IL-1ß signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog. 2012; 8(11):e1003039.
        View in: PubMed
      39. Lauring AS, Lee TH, Martin JN, Hunt PW, Deeks SG, Busch M. Lack of evidence for mtDNA as a biomarker of innate immune activation in HIV infection. PLoS One. 2012; 7(11):e50486.
        View in: PubMed
      40. Mexas AM, Graf EH, Pace MJ, Yu JJ, Papasavvas E, Azzoni L, Busch MP, Di Mascio M, Foulkes AS, Migueles SA, Montaner LJ, O'Doherty U. Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials. AIDS. 2012 Nov 28; 26(18):2295-306.
        View in: PubMed
      41. Hatano H, Scherzer R, Wu Y, Harvill K, Maka K, Hoh R, Sinclair E, Palmer S, Martin JN, Busch MP, Deeks SG, Hsue PY. A randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection. J Acquir Immune Defic Syndr. 2012 Nov 1; 61(3):317-25.
        View in: PubMed
      42. Azzoni L, Foulkes AS, Papasavvas E, Mexas AM, Lynn KM, Mounzer K, Tebas P, Jacobson JM, Frank I, Busch MP, Deeks SG, Carrington M, O'Doherty U, Kostman J, Montaner LJ. Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration. J Infect Dis. 2013 Jan 15; 207(2):213-22.
        View in: PubMed
      43. Bloch EM, Jackman RP, Lee TH, Busch MP. Transfusion-associated microchimerism: the hybrid within. Transfus Med Rev. 2013 Jan; 27(1):10-20.
        View in: PubMed
      44. Page K, Osburn W, Evans J, Hahn JA, Lum P, Asher A, Delwart E, Tobler L, Cox AL, Busch MP. Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection. Clin Infect Dis. 2013 Feb; 56(3):405-13.
        View in: PubMed
      45. Hatano H, Jain V, Hunt PW, Lee TH, Sinclair E, Do TD, Hoh R, Martin JN, McCune JM, Hecht F, Busch MP, Deeks SG. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. J Infect Dis. 2013 Jul; 208(1):50-6.
        View in: PubMed
      46. Keating SM, Hanson D, Lebedeva M, Laeyendecker O, Ali-Napo NL, Owen SM, Stramer SL, Moore RD, Norris PJ, Busch MP. Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation. J Clin Microbiol. 2012 Dec; 50(12):3968-76.
        View in: PubMed
      47. Pybus OG, Suchard MA, Lemey P, Bernardin FJ, Rambaut A, Crawford FW, Gray RR, Arinaminpathy N, Stramer SL, Busch MP, Delwart EL. Unifying the spatial epidemiology and molecular evolution of emerging epidemics. Proc Natl Acad Sci U S A. 2012 Sep 11; 109(37):15066-71.
        View in: PubMed
      48. de Almeida-Neto C, Sabino EC, Liu J, Blatyta PF, Mendrone-Junior A, Salles NA, Leão SC, Wright DJ, Basques FV, Ferreira JE, Busch MP, Murphy EL. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus. Transfusion. 2013 Apr; 53(4):827-34.
        View in: PubMed
      49. Lanteri MC, Busch MP. Dengue in the context of "safe blood" and global epidemiology: to screen or not to screen? Transfusion. 2012 Aug; 52(8):1634-9.
        View in: PubMed
      50. Gallagher LM, Ganz PR, Yang H, Kessler DA, O'Brien SF, Custer BS, Busch MP, Dodd RY, Stramer SL, Walderhaug MO, Forshee RA, Williams AE, Epstein JS, Anderson SA. Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop. Transfusion. 2013 Feb; 53(2):455-63.
        View in: PubMed
      51. Leal É, Casseb J, Hendry M, Busch MP, Diaz RS. Relaxation of adaptive evolution during the HIV-1 infection owing to reduction of CD4+ T cell counts. PLoS One. 2012; 7(6):e39776.
        View in: PubMed
      52. Glynn SA, Busch MP, Dodd RY, Katz LM, Stramer SL, Klein HG, Simmons G, Kleinman SH, Shurin SB. Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century. Transfusion. 2013 Feb; 53(2):438-54.
        View in: PubMed
      53. Saadai P, Lee TH, Bautista G, Gonzales KD, Nijagal A, Busch MP, Kim CJ, Romero R, Lee H, Hirose S, Rand L, Miniati D, Farmer DL, MacKenzie TC. Alterations in maternal-fetal cellular trafficking after fetal surgery. J Pediatr Surg. 2012 Jun; 47(6):1089-94.
        View in: PubMed
      54. Uccellini L, Tseng FC, Monaco A, Shebl FM, Pfeiffer R, Dotrang M, Buckett D, Busch MP, Wang E, Edlin BR, Marincola FM, O'Brien TR. HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations. Hepatology. 2012 Jul; 56(1):86-94.
        View in: PubMed
      55. Parrish NF, Wilen CB, Banks LB, Iyer SS, Pfaff JM, Salazar-Gonzalez JF, Salazar MG, Decker JM, Parrish EH, Berg A, Hopper J, Hora B, Kumar A, Mahlokozera T, Yuan S, Coleman C, Vermeulen M, Ding H, Ochsenbauer C, Tilton JC, Permar SR, Kappes JC, Betts MR, Busch MP, Gao F, Montefiori D, Haynes BF, Shaw GM, Hahn BH, Doms RW. Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin a4ß7. PLoS Pathog. 2012; 8(5):e1002686.
        View in: PubMed
      56. Kleinman S, King MR, Busch MP, Murphy EL, Glynn SA. The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability. Transfus Med Rev. 2012 Oct; 26(4):281-304, 304.e1-2.
        View in: PubMed
      57. Selvarajah S, Keating S, Heitman J, Lu K, Simmons G, Norris PJ, Operskalski E, Mosley JW, Busch MP. Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection. J Gen Virol. 2012 Aug; 93(Pt 8):1673-9.
        View in: PubMed
      58. Busch MP, Murthy KK, Kleinman SH, Hirschkorn DF, Herring BL, Delwart EL, Racanelli V, Yoon JC, Rehermann B, Alter HJ. Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomes. Blood. 2012 Jun 28; 119(26):6326-34.
        View in: PubMed
      59. Goncalez TT, Sabino EC, Capuani L, Liu J, Wright DJ, Walsh JH, Ferreira JE, Chamone DA, Busch MP, Custer B. Blood transfusion utilization and recipient survival at Hospital das Clinicas in São Paulo, Brazil. Transfusion. 2012 Apr; 52(4):729-38.
        View in: PubMed
      60. Carson PJ, Borchardt SM, Custer B, Prince HE, Dunn-Williams J, Winkelman V, Tobler L, Biggerstaff BJ, Lanciotti R, Petersen LR, Busch MP. Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008. Emerg Infect Dis. 2012 Apr; 18(4):684-6.
        View in: PubMed
      61. Jackman RP, Utter GH, Muench MO, Heitman JW, Munz MM, Jackman RW, Biswas HH, Rivers RM, Tobler LH, Busch MP, Norris PJ. Distinct roles of trauma and transfusion in induction of immune modulation after injury. Transfusion. 2012 Dec; 52(12):2533-50.
        View in: PubMed
      62. Baum PD, Young JJ, Schmidt D, Zhang Q, Hoh R, Busch M, Martin J, Deeks S, McCune JM. Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persists. Blood. 2012 Apr 12; 119(15):3469-77.
        View in: PubMed
      63. Manak M, Sina S, Anekella B, Hewlett I, Sanders-Buell E, Ragupathy V, Kim J, Vermeulen M, Stramer SL, Sabino E, Grabarczyk P, Michael N, Peel S, Garrett P, Tovanabutra S, Busch MP, Schito M. Pilot studies for development of an HIV subtype panel for surveillance of global diversity. AIDS Res Hum Retroviruses. 2012 Jun; 28(6):594-606.
        View in: PubMed
      64. Stramer SL, Collins C, Nugent T, Wang X, Fuschino M, Heitman JW, Law J, Krysztof DE, Kiely N, Todd D, Vermeulen NM, Harrington K, Kamel H, Kelvin DJ, Busch MP, St George K, Hewlett IK, Linnen JM, Norris PJ. Sensitive detection assays for influenza RNA do not reveal viremia in US blood donors. J Infect Dis. 2012 Mar 15; 205(6):886-94.
        View in: PubMed
      65. Delwart E, Slikas E, Stramer SL, Kamel H, Kessler D, Krysztof D, Tobler LH, Carrick DM, Steele W, Todd D, Wright DJ, Kleinman SH, Busch MP. Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. J Infect Dis. 2012 Mar 15; 205(6):875-85.
        View in: PubMed
      66. Murphy EL, Schlumpf K, Wright DJ, Cable R, Roback J, Sacher R, Busch MP. BMI and obesity in US blood donors: a potential public health role for the blood centre. Public Health Nutr. 2012 Jun; 15(6):964-71.
        View in: PubMed
      67. Mast AE, Lee TH, Schlumpf KS, Wright DJ, Johnson B, Carrick DM, Cable RG, Kiss JE, Glynn SA, Steele WR, Murphy EL, Sacher R, Busch MP. The impact of HFE mutations on haemoglobin and iron status in individuals experiencing repeated iron loss through blood donation*. Br J Haematol. 2012 Feb; 156(3):388-401.
        View in: PubMed
      68. Sanchez R, Lee TH, Wen L, Montalvo L, Schechterly C, Colvin C, Alter HJ, Luban NL, Busch MP. Absence of transfusion-associated microchimerism in pediatric and adult recipients of leukoreduced and gamma-irradiated blood components. Transfusion. 2012 May; 52(5):936-45.
        View in: PubMed
      69. Simmons G, Glynn SA, Komaroff AL, Mikovits JA, Tobler LH, Hackett J, Tang N, Switzer WM, Heneine W, Hewlett IK, Zhao J, Lo SC, Alter HJ, Linnen JM, Gao K, Coffin JM, Kearney MF, Ruscetti FW, Pfost MA, Bethel J, Kleinman S, Holmberg JA, Busch MP. Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science. 2011 Nov 11; 334(6057):814-7.
        View in: PubMed
      70. Bigham AW, Buckingham KJ, Husain S, Emond MJ, Bofferding KM, Gildersleeve H, Rutherford A, Astakhova NM, Perelygin AA, Busch MP, Murray KO, Sejvar JJ, Green S, Kriesel J, Brinton MA, Bamshad M. Host genetic risk factors for West Nile virus infection and disease progression. PLoS One. 2011; 6(9):e24745.
        View in: PubMed
      71. Hecht FM, Wellman R, Busch MP, Pilcher CD, Norris PJ, Margolick JB, Collier AC, Little SJ, Markowitz M, Routy JP, Holte S. Identifying the early post-HIV antibody seroconversion period. J Infect Dis. 2011 Aug 15; 204(4):526-33.
        View in: PubMed
      72. Dias PT, Hahn JA, Delwart E, Edlin B, Martin J, Lum P, Evans J, Kral A, Deeks S, Busch MP, Page K. Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California. BMC Infect Dis. 2011; 11:208.
        View in: PubMed
      73. Lanteri MC, Kaidarova Z, Peterson T, Cate S, Custer B, Wu S, Agapova M, Law JP, Bielawny T, Plummer F, Tobler LH, Loeb M, Busch MP, Bramson J, Luo M, Norris PJ. Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study. PLoS One. 2011; 6(8):e22948.
        View in: PubMed
      74. Patavino GM, de Almeida-Neto C, Liu J, Wright DJ, Mendrone-Junior A, Ferreira MI, Carneiro AB, Custer B, Ferreira JE, Busch MP, Sabino EC. Number of recent sexual partners among blood donors in Brazil: associations with donor demographics, donation characteristics, and infectious disease markers. Transfusion. 2012 Jan; 52(1):151-9.
        View in: PubMed
      75. Kassanjee R, Welte A, McWalter TA, Keating SM, Vermeulen M, Stramer SL, Busch MP. Seroconverting blood donors as a resource for characterising and optimising recent infection testing algorithms for incidence estimation. PLoS One. 2011; 6(6):e20027.
        View in: PubMed
      76. Shimokura G, Chai F, Weber DJ, Samsa GP, Xia GL, Nainan OV, Tobler LH, Busch MP, Alter MJ. Patient-care practices associated with an increased prevalence of hepatitis C virus infection among chronic hemodialysis patients. Infect Control Hosp Epidemiol. 2011 May; 32(5):415-24.
        View in: PubMed
      77. Lanteri MC, Diamond MS, Norris PJ, Busch MP. [West Nile virus. II. Immunopathophysiology in humans]. Med Sci (Paris). 2011 Apr; 27(4):382-6.
        View in: PubMed
      78. Lanteri MC, Assal A, Norris PJ, Busch MP. [West Nile virus - I. conquest of the West]. Med Sci (Paris). 2011 Apr; 27(4):375-81.
        View in: PubMed
      79. Hatano H, Hayes TL, Dahl V, Sinclair E, Lee TH, Hoh R, Lampiris H, Hunt PW, Palmer S, McCune JM, Martin JN, Busch MP, Shacklett BL, Deeks SG. A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. J Infect Dis. 2011 Apr 1; 203(7):960-8.
        View in: PubMed
      80. Delwart E, Bernardin F, Lee TH, Winkelman V, Liu C, Sheppard H, Liu A, Greenblatt R, Anastos K, DeHovitz J, Nowicki M, Cohen M, Golub ET, Barbour J, Buchbinder S, Busch MP. Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women. AIDS. 2011 Mar 13; 25(5):619-23.
        View in: PubMed
      81. Simmons G, Glynn SA, Holmberg JA, Coffin JM, Hewlett IK, Lo SC, Mikovits JA, Switzer WM, Linnen JM, Busch MP. The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plans. Transfusion. 2011 Mar; 51(3):643-53.
        View in: PubMed
      82. Carrick DM, Norris PJ, Endres RO, Pandey S, Kleinman SH, Wright D, Sun Y, Busch MP. Establishing assay cutoffs for HLA antibody screening of apheresis donors. Transfusion. 2011 Oct; 51(10):2092-101.
        View in: PubMed
      83. Lee TH, Kleinman SH, Wen L, Montalvo L, Todd DS, Wright DJ, Tobler LH, Busch MP. Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors. Transfusion. 2011 Sep; 51(9):1896-908.
        View in: PubMed
      84. Hunt PW, Landay AL, Sinclair E, Martinson JA, Hatano H, Emu B, Norris PJ, Busch MP, Martin JN, Brooks C, McCune JM, Deeks SG. A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One. 2011; 6(1):e15924.
        View in: PubMed
      85. Zeremski M, Hooker G, Shu MA, Winkelstein E, Brown Q, Des Jarlais DC, Tobler LH, Rehermann B, Busch MP, Edlin BR, Talal AH. Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection. J Hepatol. 2011 Sep; 55(3):545-53.
        View in: PubMed
      86. Hunt PW, Hatano H, Sinclair E, Lee TH, Busch MP, Martin JN, McCune JM, Deeks SG. HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers. Clin Infect Dis. 2011 Mar 1; 52(5):681-7.
        View in: PubMed
      87. Sabino EC, Salles NA, de Almeida-Neto C, Barreto AM, Basques F, Barros EA, Mendrone A, Busch MP. Performance of parallel screening of Brazilian blood donors with two human immunodeficiency virus immunoassays: implications for sequential immunoassay testing algorithms in other countries. Transfusion. 2011 Jan; 51(1):175-83.
        View in: PubMed
      88. de Almeida-Neto C, Liu J, Wright DJ, Mendrone-Junior A, Takecian PL, Sun Y, Ferreira JE, de Alencar Fischer Chamone D, Busch MP, Sabino EC. Demographic characteristics and prevalence of serologic markers among blood donors who use confidential unit exclusion (CUE) in São Paulo, Brazil: implications for modification of CUE policies in Brazil. Transfusion. 2011 Jan; 51(1):191-7.
        View in: PubMed
      89. Jackman RP, Utter GH, Heitman JW, Hirschkorn DF, Law JP, Gefter N, Busch MP, Norris PJ. Effects of blood sample age at time of separation on measured cytokine concentrations in human plasma. Clin Vaccine Immunol. 2011 Feb; 18(2):318-26.
        View in: PubMed
      90. Sabino EC, Salles NA, Sarr M, Barreto AM, Oikawa M, Oliveira CD, Leao SC, Carneiro-Proietti AB, Custer B, Busch MP. Enhanced classification of Chagas serologic results and epidemiologic characteristics of seropositive donors at three large blood centers in Brazil. Transfusion. 2010 Dec; 50(12):2628-37.
        View in: PubMed
      91. Busch MP, Pilcher CD, Mastro TD, Kaldor J, Vercauteren G, Rodriguez W, Rousseau C, Rehle TM, Welte A, Averill MD, Garcia Calleja JM. Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS. 2010 Nov 27; 24(18):2763-71.
        View in: PubMed
      92. Carrick DM, Johnson B, Kleinman SH, Vorhaben R, Chance SC, Lee JH, Roback JD, Pandey S, Sun Y, Busch MP, Norris PJ. Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff. Transfusion. 2011 May; 51(5):1105-16.
        View in: PubMed
      93. Selvarajah S, Tobler LH, Simmons G, Busch MP. Host genetic basis for hepatitis C virus clearance: a role for blood collection centers. Curr Opin Hematol. 2010 Nov; 17(6):550-7.
        View in: PubMed
      94. Gottschall JL, Triulzi DJ, Curtis B, Kakaiya RM, Busch MP, Norris PJ, Glynn SA, Carrick D, Wright DJ, Kleinman S. The frequency and specificity of human neutrophil antigen antibodies in a blood donor population. Transfusion. 2011 Apr; 51(4):820-7.
        View in: PubMed
      95. Hatano H, Delwart EL, Norris PJ, Lee TH, Neilands TB, Kelley CF, Hunt PW, Hoh R, Linnen JM, Martin JN, Busch MP, Deeks SG. Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals. AIDS. 2010 Oct 23; 24(16):2535-9.
        View in: PubMed
      96. Cohen MS, Gay CL, Busch MP, Hecht FM. The detection of acute HIV infection. J Infect Dis. 2010 Oct 15; 202 Suppl 2:S270-7.
        View in: PubMed
      97. Agapova M, Busch MP, Custer B. Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi. Transfusion. 2010 Oct; 50(10):2220-32.
        View in: PubMed
      98. Lee TH, Chafets DM, Biggar RJ, McCune JM, Busch MP. The role of transplacental microtransfusions of maternal lymphocytes in in utero HIV transmission. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):143-7.
        View in: PubMed
      99. Perkins HA, Busch MP. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion. 2010 Oct; 50(10):2080-99.
        View in: PubMed
      100. Scott EA, Schlumpf KS, Mathew SM, Mast AE, Busch MP, Gottschall JL. Biospecimen repositories: are blood donors willing to participate? Transfusion. 2010 Sep; 50(9):1943-50.
        View in: PubMed
      101. Rice MS, Custer BS, Hindes DA, Hirschler NV, Nguyen KA, Busch MP, Murphy EL. Genetic research in the blood bank: acceptability to Northern California donors. Transfusion. 2010 Sep; 50(9):1951-8.
        View in: PubMed
      102. Murphy EL, Fang J, Tu Y, Cable R, Hillyer CD, Sacher R, Triulzi D, Gottschall JL, Busch MP. Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index. J Infect Dis. 2010 Aug 15; 202(4):576-84.
        View in: PubMed
      103. Bebell LM, Pilcher CD, Dorsey G, Havlir D, Kamya MR, Busch MP, Dunn Williams J, Nugent CT, Bentsen C, Rosenthal PJ, Charlebois ED. Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria. AIDS. 2010 Jul 31; 24(12):1945-52.
        View in: PubMed
      104. Schito ML, D'Souza MP, Owen SM, Busch MP. Challenges for rapid molecular HIV diagnostics. J Infect Dis. 2010 Apr 15; 201 Suppl 1:S1-6.
        View in: PubMed
      105. Tobler LH, Bahrami SH, Kaidarova Z, Pitina L, Winkelman VK, Vanderpool SK, Guiltinan AM, Cooper S, Busch MP, Murphy EL. A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME). Transfusion. 2010 Jul; 50(7):1513-23.
        View in: PubMed
      106. Mbisa GL, Miley W, Gamache CJ, Gillette WK, Esposito D, Hopkins R, Busch MP, Schreiber GB, Little RF, Yarchoan R, Ortiz-Conde BA, Labò N, Whitby D. Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA. J Immunol Methods. 2010 Apr 30; 356(1-2):39-46.
        View in: PubMed
      107. Edgren G, Kamper-Jørgensen M, Eloranta S, Rostgaard K, Custer B, Ullum H, Murphy EL, Busch MP, Reilly M, Melbye M, Hjalgrim H, Nyrén O. Duration of red blood cell storage and survival of transfused patients (CME). Transfusion. 2010 Jun; 50(6):1185-95.
        View in: PubMed
      108. Endres RO, Kleinman SH, Carrick DM, Steele WR, Wright DJ, Norris PJ, Triulzi D, Kakaiya R, Busch MP. Identification of specificities of antibodies against human leukocyte antigens in blood donors. Transfusion. 2010 Aug; 50(8):1749-60.
        View in: PubMed
      109. Kakaiya RM, Triulzi DJ, Wright DJ, Steele WR, Kleinman SH, Busch MP, Norris PJ, Hillyer CD, Gottschall JL, Rios JA, Carey P, Glynn SA. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion. 2010 Jun; 50(6):1328-34.
        View in: PubMed
      110. Carneiro-Proietti AB, Sabino EC, Sampaio D, Proietti FA, Gonçalez TT, Oliveira CD, Ferreira JE, Liu J, Custer B, Schreiber GB, Murphy EL, Busch MP. Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008. Transfusion. 2010 Apr; 50(4):918-25.
        View in: PubMed
      111. Khurana S, Norris PJ, Busch MP, Haynes BF, Park S, Sasono P, Mlisana K, Salim AK, Hecht FM, Mulenga J, Chomba E, Hunter E, Allen S, Nemo G, Rodriguez-Chavez IR. HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection. J Clin Microbiol. 2010 Jan; 48(1):281-5.
        View in: PubMed
      112. Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, Tobler L, Andrews W, Avanesyan L, Cooper S, Busch MP. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis. 2009 Oct 15; 200(8):1216-26.
        View in: PubMed
      113. Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, Heitman JW, Custer B, Hirschkorn DF, Tobler LH, Kiely N, Prince HE, Ndhlovu LC, Nixon DF, Kamel HT, Kelvin DJ, Busch MP, Rudensky AY, Diamond MS, Norris PJ. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest. 2009 Nov; 119(11):3266-77.
        View in: PubMed
      114. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009 Oct 8; 461(7265):798-801.
        View in: PubMed
      115. Kleinman SH, Glynn SA, Lee TH, Tobler LH, Schlumpf KS, Todd DS, Qiao H, Yu MY, Busch MP. A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion. Blood. 2009 Oct 22; 114(17):3677-83.
        View in: PubMed
      116. Lee HY, Giorgi EE, Keele BF, Gaschen B, Athreya GS, Salazar-Gonzalez JF, Pham KT, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Hahn BH, Shaw GM, Korber BT, Bhattacharya T, Perelson AS. Modeling sequence evolution in acute HIV-1 infection. J Theor Biol. 2009 Nov 21; 261(2):341-60.
        View in: PubMed
      117. Kleinman SH, Lelie N, Busch MP. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion. 2009 Nov; 49(11):2454-89.
        View in: PubMed
      118. Busch MP, Glynn SA. Use of blood-donor and transfusion-recipient biospecimen repositories to address emerging blood-safety concerns and advance infectious disease research: the National Heart, Lung, and Blood Institute Biologic Specimen Repository. J Infect Dis. 2009 Jun 1; 199(11):1564-6.
        View in: PubMed
      119. Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion. 2009 Sep; 49(9):1825-35.
        View in: PubMed
      120. Edlin BR, Shu MA, Winkelstein E, Des Jarlais DC, Busch MP, Rehermann B, O'Brien TR, Talal AH, Tobler LH, Zeremski M, Beeder AB. More rare birds, and the occasional swan. Gastroenterology. 2009 Jun; 136(7):2412-4.
        View in: PubMed
      121. Kleinman SH, Williams JD, Robertson G, Caglioti S, Williams RC, Spizman R, Morgan L, Tomasulo P, Busch MP. West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing. Transfusion. 2009 Jun; 49(6):1160-70.
        View in: PubMed
      122. Anderson SA, Yang H, Gallagher LM, O'Callaghan S, Forshee RA, Busch MP, McKenna MT, Williams I, Williams A, Kuehnert MJ, Stramer S, Kleinman S, Epstein J, Dayton AI. Quantitative estimate of the risks and benefits of possible alternative blood donor deferral strategies for men who have had sex with men. Transfusion. 2009 Jun; 49(6):1102-14.
        View in: PubMed
      123. Busch M, Walderhaug M, Custer B, Allain JP, Reddy R, McDonough B. Risk assessment and cost-effectiveness/utility analysis. Biologicals. 2009 Apr; 37(2):78-87.
        View in: PubMed
      124. Custer B, Kamel H, Kiely NE, Murphy EL, Busch MP. Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion. 2009 Feb; 49(2):278-88.
        View in: PubMed
      125. Ma ZM, Stone M, Piatak M, Schweighardt B, Haigwood NL, Montefiori D, Lifson JD, Busch MP, Miller CJ. High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J Virol. 2009 Apr; 83(7):3288-97.
        View in: PubMed
      126. Mold JE, Michaëlsson J, Burt TD, Muench MO, Beckerman KP, Busch MP, Lee TH, Nixon DF, McCune JM. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science. 2008 Dec 5; 322(5907):1562-5.
        View in: PubMed
      127. Biggar RJ, Lee TH, Wen L, Broadhead R, Kumwenda N, Taha TE, Busch MP. The role of transplacental microtransfusions of maternal lymphocytes in HIV transmission to newborns. AIDS. 2008 Nov 12; 22(17):2251-6.
        View in: PubMed
      128. Norris PJ, Lee JH, Carrick DM, Gottschall JL, Lebedeva M, de Castro BR, Kleinman SH, Busch MP. Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma. Transfusion. 2009 Feb; 49(2):243-51.
        View in: PubMed
      129. Hatano H, Delwart EL, Norris PJ, Lee TH, Dunn-Williams J, Hunt PW, Hoh R, Stramer SL, Linnen JM, McCune JM, Martin JN, Busch MP, Deeks SG. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol. 2009 Jan; 83(1):329-35.
        View in: PubMed
      130. Tobler LH, Cameron MJ, Lanteri MC, Prince HE, Danesh A, Persad D, Lanciotti RS, Norris PJ, Kelvin DJ, Busch MP. Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors. J Infect Dis. 2008 Oct 1; 198(7):979-83.
        View in: PubMed
      131. Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, Walsh I, Matud JL, Prince HE, Lanciotti RS, Wright DJ, Linnen JM, Caglioti S. Virus and antibody dynamics in acute west nile virus infection. J Infect Dis. 2008 Oct 1; 198(7):984-93.
        View in: PubMed
      132. Mizukoshi E, Eisenbach C, Edlin BR, Newton KP, Raghuraman S, Weiler-Normann C, Tobler LH, Busch MP, Carrington M, McKeating JA, O'Brien TR, Rehermann B. Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. J Infect Dis. 2008 Jul 15; 198(2):203-12.
        View in: PubMed
      133. Utter GH, Lee TH, Rivers RM, Montalvo L, Wen L, Chafets DM, Reed WF, Busch MP. Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean, and World War II conflicts. Transfusion. 2008 Aug; 48(8):1609-15.
        View in: PubMed
      134. Linnen JM, Vinelli E, Sabino EC, Tobler LH, Hyland C, Lee TH, Kolk DP, Broulik AS, Collins CS, Lanciotti RS, Busch MP. Dengue viremia in blood donors from Honduras, Brazil, and Australia. Transfusion. 2008 Jul; 48(7):1355-62.
        View in: PubMed
      135. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, Wei X, Jiang C, Kirchherr JL, Gao F, Anderson JA, Ping LH, Swanstrom R, Tomaras GD, Blattner WA, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Cohen MS, Montefiori DC, Haynes BF, Gaschen B, Athreya GS, Lee HY, Wood N, Seoighe C, Perelson AS, Bhattacharya T, Korber BT, Hahn BH, Shaw GM. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A. 2008 May 27; 105(21):7552-7.
        View in: PubMed
      136. Prince HE, Lapé-Nixon M, Yeh C, Tobler LH, Busch MP. Persistence of antibodies to West Nile virus nonstructural protein 5. J Clin Virol. 2008 Sep; 43(1):102-6.
        View in: PubMed
      137. Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion. 2008 Aug; 48(8):1558-66.
        View in: PubMed
      138. Lanteri MC, Heitman JW, Owen RE, Busch T, Gefter N, Kiely N, Kamel HT, Tobler LH, Busch MP, Norris PJ. Comprehensive analysis of west nile virus-specific T cell responses in humans. J Infect Dis. 2008 May 1; 197(9):1296-306.
        View in: PubMed
      139. Dunne JR, Lee TH, Burns C, Cardo LJ, Curry K, Busch MP. Transfusion-associated microchimerism in combat casualties. J Trauma. 2008 Feb; 64(2 Suppl):S92-7; discussion S97-8.
        View in: PubMed
      140. Guiltinan AM, Kaidarova Z, Custer B, Orland J, Strollo A, Cyrus S, Busch MP, Murphy EL. Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors. Am J Epidemiol. 2008 Mar 15; 167(6):743-50.
        View in: PubMed
      141. Gill RM, Lee TH, Utter GH, Reed WF, Wen L, Chafets D, Busch MP. The TNF (-308A) polymorphism is associated with microchimerism in transfused trauma patients. Blood. 2008 Apr 1; 111(7):3880-3.
        View in: PubMed
      142. Bacchetti P, Tien PC, Seaberg EC, O'Brien TR, Augenbraun MH, Kral AH, Busch MP, Edlin BR. Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression. BMC Infect Dis. 2007; 7:145.
        View in: PubMed
      143. Page-Shafer K, Pappalardo BL, Tobler LH, Phelps BH, Edlin BR, Moss AR, Wright TL, Wright DJ, O'Brien TR, Caglioti S, Busch MP. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol. 2008 Feb; 46(2):499-506.
        View in: PubMed
      144. Benjamin RJ, Busch MP, Fang CT, Notari EP, Puren A, Schoub BD, Tobler LH, Hogrefe W, du P Heyns A, Stramer SL, Crookes RL. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations. Transfusion. 2008 Feb; 48(2):295-303.
        View in: PubMed
      145. Kleinman SH, Glynn SA, Lee TH, Tobler L, Montalvo L, Todd D, Kiss JE, Shyamala V, Busch MP. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion. 2007 Oct; 47(10):1756-64.
        View in: PubMed
      146. Tseng FC, O'Brien TR, Zhang M, Kral AH, Ortiz-Conde BA, Lorvick J, Busch MP, Edlin BR. Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000. Hepatology. 2007 Sep; 46(3):666-71.
        View in: PubMed
      147. Klimashevskaya S, Obriadina A, Ulanova T, Bochkova G, Burkov A, Araujo A, Stramer SL, Tobler LH, Busch MP, Fields HA. Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of anti-HCV immunoglobulin G avidity index. J Clin Microbiol. 2007 Oct; 45(10):3400-3.
        View in: PubMed
      148. Custer B, Chinn A, Hirschler NV, Busch MP, Murphy EL. The consequences of temporary deferral on future whole blood donation. Transfusion. 2007 Aug; 47(8):1514-23.
        View in: PubMed
      149. Zetola NM, Mintie A, Liska S, Wong E, Williams JD, Busch MP, Klausner JD. Performance of a transcription-mediated-amplification HIV-1 RNA assay in pooled specimens. J Clin Virol. 2007 Sep; 40(1):68-70.
        View in: PubMed
      150. Prince HE, Tobler LH, Yeh C, Gefter N, Custer B, Busch MP. Persistence of West Nile virus-specific antibodies in viremic blood donors. Clin Vaccine Immunol. 2007 Sep; 14(9):1228-30.
        View in: PubMed
      151. Allain JP, Busch MP. Donation archives and prospective donor-recipient repositories: indispensable tools for monitoring blood safety. Transfusion. 2007 Jul; 47(7):1110-4.
        View in: PubMed
      152. Oceguera LF, Patiris PJ, Chiles RE, Busch MP, Tobler LH, Hanson CV. Flavivirus serology by Western blot analysis. Am J Trop Med Hyg. 2007 Jul; 77(1):159-63.
        View in: PubMed
      153. Herring BL, Bernardin F, Caglioti S, Stramer S, Tobler L, Andrews W, Cheng L, Rampersad S, Cameron C, Saldanha J, Busch MP, Delwart E. Phylogenetic analysis of WNV in North American blood donors during the 2003-2004 epidemic seasons. Virology. 2007 Jun 20; 363(1):220-8.
        View in: PubMed
      154. Reed W, Lee TH, Norris PJ, Utter GH, Busch MP. Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients. Semin Hematol. 2007 Jan; 44(1):24-31.
        View in: PubMed
      155. Tobler LH, Contestable P, Pitina L, Pitina L, Groth H, Shaffer S, Blackburn GR, Warren H, Lee SR, Busch MP. Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors. Transfusion. 2007 Jan; 47(1):90-6.
        View in: PubMed
      156. Busch MR. Evolving approaches to estimate risks of transfusion-transmitted viral infections: incidence-window period model after ten years. Dev Biol (Basel). 2007; 127:87-112.
        View in: PubMed
      157. Stramer SL, Custer B, Busch MP, Dodd RY. Strategies for testing blood donors for West Nile virus. Transfusion. 2006 Dec; 46(12):2036-7.
        View in: PubMed
      158. Utter GH, Nathens AB, Lee TH, Reed WF, Owings JT, Nester TA, Busch MP. Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in trauma patients. Transfusion. 2006 Nov; 46(11):1863-9.
        View in: PubMed
      159. Lee TH, Chafets DM, Reed W, Wen L, Yang Y, Chen J, Utter GH, Owings JT, Busch MP. Enhanced ascertainment of microchimerism with real-time quantitative polymerase chain reaction amplification of insertion-deletion polymorphisms. Transfusion. 2006 Nov; 46(11):1870-8.
        View in: PubMed
      160. Khurana S, Needham J, Park S, Mathieson B, Busch MP, Nemo G, Nyambi P, Zolla-Pazner S, Laal S, Mulenga J, Chomba E, Hunter E, Allen S, McIntyre J, Hewlett I, Lee S, Tang S, Cowan E, Beyrer C, Altfeld M, Yu XG, Tounkara A, Koita O, Kamali A, Nguyen N, Graham BS, Todd D, Mugenyi P, Anzala O, Sanders E, Ketter N, Fast P, Golding H. Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes. J Acquir Immune Defic Syndr. 2006 Nov 1; 43(3):304-12.
        View in: PubMed
      161. Busch MP. Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors. Transfusion. 2006 Oct; 46(10):1663-6.
        View in: PubMed
      162. Kamel HT, Bassett MB, Custer B, Paden CJ, Strollo AM, McEvoy P, Busch MP, Tomasulo PA. Safety and donor acceptance of an abbreviated donor history questionnaire. Transfusion. 2006 Oct; 46(10):1745-53.
        View in: PubMed
      163. Busch MP. Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis. Transfusion. 2006 Sep; 46(9):1624-40.
        View in: PubMed
      164. Norris PJ, Pappalardo BL, Custer B, Spotts G, Hecht FM, Busch MP. Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses. 2006 Aug; 22(8):757-62.
        View in: PubMed
      165. Killian MS, Norris PJ, Rawal BD, Lebedeva M, Hecht FM, Levy JA, Busch MP. The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response. AIDS Res Hum Retroviruses. 2006 Jul; 22(7):640-7.
        View in: PubMed
      166. Kleinman SH, Busch MP. Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol. 2006 May; 36 Suppl 1:S23-9.
        View in: PubMed
      167. Kleinman SH, Stramer SL, Brodsky JP, Caglioti S, Busch MP. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms. Transfusion. 2006 May; 46(5):695-702.
        View in: PubMed
      168. Baxter-Lowe LA, Busch MP. Tracking microchimeric DNA in plasma to diagnose and manage organ transplant rejection. Clin Chem. 2006 Apr; 52(4):559-61.
        View in: PubMed
      169. Barreto CC, Nishyia A, Araújo LV, Ferreira JE, Busch MP, Sabino EC. Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil. J Acquir Immune Defic Syndr. 2006 Mar; 41(3):338-41.
        View in: PubMed
      170. Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, Kleinman SH, Prince HE, Bianco C, Foster G, Petersen LR, Nemo G, Glynn SA. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis. 2006 Mar; 12(3):395-402.
        View in: PubMed
      171. Busch MP, Glynn SA, Stramer SL, Orland J, Murphy EL, Wright DJ, Kleinman S. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors. Transfusion. 2006 Mar; 46(3):469-75.
        View in: PubMed
      172. Heyns Adu P, Benjamin RJ, Swanevelder JP, Laycock ME, Pappalardo BL, Crookes RL, Wright DJ, Busch MP. Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa. JAMA. 2006 Feb 1; 295(5):519-26.
        View in: PubMed
      173. Hare CB, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, Alexander SS, Bentsen C, Ramstead CA, Nixon DF, Levy JA, Hecht FM. Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection. Clin Infect Dis. 2006 Mar 1; 42(5):700-8.
        View in: PubMed
      174. Delwart E, Kuhns MC, Busch MP. Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology. J Med Virol. 2006; 78 Suppl 1:S30-5.
        View in: PubMed
      175. Fox JL, Hazell SL, Tobler LH, Busch MP. Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus. Clin Vaccine Immunol. 2006 Jan; 13(1):33-6.
        View in: PubMed
      176. Kuhns MC, Busch MP. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods. Mol Diagn Ther. 2006; 10(2):77-91.
        View in: PubMed
      177. Busch MP, Glynn SA, Wright DJ, Hirschkorn D, Laycock ME, McAuley J, Tu Y, Giachetti C, Gallarda J, Heitman J, Kleinman SH. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection. Transfusion. 2005 Dec; 45(12):1853-63.
        View in: PubMed
      178. Barreto CC, Sabino EC, Gonçalez TT, Laycock ME, Pappalardo BL, Salles NA, Wright DJ, Chamone DF, Busch MP. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil. Transfusion. 2005 Nov; 45(11):1709-14.
        View in: PubMed
      179. Roland ME, Neilands TB, Krone MR, Katz MH, Franses K, Grant RM, Busch MP, Hecht FM, Shacklett BL, Kahn JO, Bamberger JD, Coates TJ, Chesney MA, Martin JN. Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clin Infect Dis. 2005 Nov 15; 41(10):1507-13.
        View in: PubMed
      180. Custer B, Busch MP, Marfin AA, Petersen LR. The cost-effectiveness of screening the U.S. blood supply for West Nile virus. Ann Intern Med. 2005 Oct 4; 143(7):486-92.
        View in: PubMed
      181. Lennette ET, Busch MP, Hecht FM, Levy JA. Potential herpesvirus interaction during HIV type 1 primary infection. AIDS Res Hum Retroviruses. 2005 Oct; 21(10):869-75.
        View in: PubMed
      182. Prince HE, Tobler LH, Lapé-Nixon M, Foster GA, Stramer SL, Busch MP. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. J Clin Microbiol. 2005 Sep; 43(9):4316-20.
        View in: PubMed
      183. Prince HE, Lapé-Nixon M, Busch MP, Tobler LH, Foster GA, Stramer SL. Utilization of follow-up specimens from viremic blood donors to assess the value of west nile virus immunoglobulin G avidity as an indicator of recent infection. Clin Diagn Lab Immunol. 2005 Sep; 12(9):1123-6.
        View in: PubMed
      184. Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Murphy EL, Busch MP. Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply. Med Decis Making. 2005 Sep-Oct; 25(5):571-82.
        View in: PubMed
      185. Busch MP, Hecht FM. Nucleic acid amplification testing for diagnosis of acute HIV infection: has the time come? AIDS. 2005 Aug 12; 19(12):1317-9.
        View in: PubMed
      186. Busch MP, Caglioti S, Robertson EF, McAuley JD, Tobler LH, Kamel H, Linnen JM, Shyamala V, Tomasulo P, Kleinman SH. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med. 2005 Aug 4; 353(5):460-7.
        View in: PubMed
      187. Diaz RS, Pardini R, Catroxo M, Operskalski EA, Mosley JW, Busch MP. HIV-1 superinfection is not a common event. J Clin Virol. 2005 Aug; 33(4):328-30.
        View in: PubMed
      188. Lee TH, Paglieroni T, Utter GH, Chafets D, Gosselin RC, Reed W, Owings JT, Holland PV, Busch MP. High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion. 2005 Aug; 45(8):1280-90.
        View in: PubMed
      189. Mosley JW, Operskalski EA, Tobler LH, Andrews WW, Phelps B, Dockter J, Giachetti C, Busch MP. Viral and host factors in early hepatitis C virus infection. Hepatology. 2005 Jul; 42(1):86-92.
        View in: PubMed
      190. Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps B, Busch MP, Page-Shafer KA. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis. 2005 Jul 15; 41(2):177-86.
        View in: PubMed
      191. Fiebig EW, Heldebrant CM, Smith RI, Conrad AJ, Delwart EL, Busch MP. Intermittent low-level viremia in very early primary HIV-1 infection. J Acquir Immune Defic Syndr. 2005 Jun 1; 39(2):133-7.
        View in: PubMed
      192. Schmidt M, Weber M, Busch MP, Tobler LH, Phelps BH, Seifried E, Roth WK. Yield of hepatitis C virus nucleic acid testing among antibody-reactive or confirmed-positive samples. Transfusion. 2005 Jun; 45(6):1040-2.
        View in: PubMed
      193. Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, Heldebrant C, Smith R, Giachetti C, Gallarda J, Busch MP. Dynamics of viremia in early hepatitis C virus infection. Transfusion. 2005 Jun; 45(6):994-1002.
        View in: PubMed
      194. Utter GH, Owings JT, Lee TH, Paglieroni TG, Reed WF, Gosselin RC, Holland PV, Busch MP. Microchimerism in transfused trauma patients is associated with diminished donor-specific lymphocyte response. J Trauma. 2005 May; 58(5):925-31; discussion 931-2.
        View in: PubMed
      195. Busch MP, Tobler LH, Saldanha J, Caglioti S, Shyamala V, Linnen JM, Gallarda J, Phelps B, Smith RI, Drebot M, Kleinman SH. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003. Transfusion. 2005 Apr; 45(4):492-9.
        View in: PubMed
      196. Busch MP, Shafer KA. Acute-phase hepatitis C virus infection: implications for research, diagnosis, and treatment. Clin Infect Dis. 2005 Apr 1; 40(7):959-61.
        View in: PubMed
      197. Sanchez AM, Schreiber GB, Nass CC, Glynn S, Kessler D, Hirschler N, Fridey J, Bethel J, Murphy E, Busch MP. The impact of male-to-male sexual experience on risk profiles of blood donors. Transfusion. 2005 Mar; 45(3):404-13.
        View in: PubMed
      198. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion. 2005 Feb; 45(2):254-64.
        View in: PubMed
      199. Elkins MK, Vittinghoff E, Baranzini SE, Hecht FM, Sriram U, Busch MP, Levy JA, Oksenberg JR. Longitudinal analysis of B cell repertoire and antibody gene rearrangements during early HIV infection. Genes Immun. 2005 Feb; 6(1):66-9.
        View in: PubMed
      200. Lee TH, Chafets DM, Busch MP, Murphy EL. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. J Clin Virol. 2004 Dec; 31(4):275-82.
        View in: PubMed
      201. Custer B, Tomasulo PA, Murphy EL, Caglioti S, Harpool D, McEvoy P, Busch MP. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion. 2004 Nov; 44(11):1547-54.
        View in: PubMed
      202. Utter GH, Owings JT, Lee TH, Paglieroni TG, Reed WF, Gosselin RC, Holland PV, Busch MP. Blood transfusion is associated with donor leukocyte microchimerism in trauma patients. J Trauma. 2004 Oct; 57(4):702-7; discussion 707-8.
        View in: PubMed
      203. Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Hirschler NV, Murphy EL, Busch MP. Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion. 2004 Oct; 44(10):1417-26.
        View in: PubMed
      204. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion. 2004 Sep; 44(9):1332-9.
        View in: PubMed
      205. Fiebig EW, Busch MP. Emerging infections in transfusion medicine. Clin Lab Med. 2004 Sep; 24(3):797-823, viii.
        View in: PubMed
      206. Barbour JD, Hecht FM, Wrin T, Liegler TJ, Ramstead CA, Busch MP, Segal MR, Petropoulos CJ, Grant RM. Persistence of primary drug resistance among recently HIV-1 infected adults. AIDS. 2004 Aug 20; 18(12):1683-9.
        View in: PubMed
      207. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med. 2004 Aug 19; 351(8):760-8.
        View in: PubMed
      208. Asmuth DM, Busch MP, Laycock ME, Mohr BA, Kalish LA, van der Horst CM. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection. Antiviral Res. 2004 Aug; 63(2):123-31.
        View in: PubMed
      209. Roland ME, Elbeik TA, Kahn JO, Bamberger JD, Coates TJ, Krone MR, Katz MH, Busch MP, Martin JN. HIV RNA testing in the context of nonoccupational postexposure prophylaxis. J Infect Dis. 2004 Aug 1; 190(3):598-604.
        View in: PubMed
      210. Barbour JD, Hecht FM, Wrin T, Segal MR, Ramstead CA, Liegler TJ, Busch MP, Petropoulos CJ, Hellmann NS, Kahn JO, Grant RM. Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection. J Infect Dis. 2004 Jul 15; 190(2):251-6.
        View in: PubMed
      211. Kleinman S, Wang B, Wu Y, Glynn SA, Williams A, Nass C, Ownby H, Busch MP. The donor notification process from the donor's perspective. Transfusion. 2004 May; 44(5):658-66.
        View in: PubMed
      212. Montalvo L, Walker P, Wen L, Lim W, Reed W, Busch MP, Lee TH. Clinical investigation of posttransfusion Kidd blood group typing using a rapid normalized quantitative polymerase chain reaction. Transfusion. 2004 May; 44(5):694-702.
        View in: PubMed
      213. Murphy EL, David Connor J, McEvoy P, Hirschler N, Busch MP, Roberts P, Nguyen KA, Reich P. Estimating blood donor loss due to the variant CJD travel deferral. Transfusion. 2004 May; 44(5):645-50.
        View in: PubMed
      214. Schreiber GB, Sanchez AM, Garratty G, Nass CC, Tu Y, Busch MP. Mammalian brain consumption by blood donors in the United States: brains today, deferred tomorrow? Transfusion. 2004 May; 44(5):667-74.
        View in: PubMed
      215. Costa LJ, Mayer AJ, Busch MP, Diaz RS. Evidence for Selection of more Adapted Human Immunodeficiency Virus Type 1 Recombinant Strains in a Dually Infected Transfusion Recipient. Virus Genes. 2004 Apr; 28(3):259-72.
        View in: PubMed
      216. Delwart EL, Kalmin ND, Jones TS, Ladd DJ, Foley B, Tobler LH, Tsui RC, Busch MP. First report of human immunodeficiency virus transmission via an RNA-screened blood donation. Vox Sang. 2004 Apr; 86(3):171-7.
        View in: PubMed
      217. Busch MP. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Transfus Clin Biol. 2004 Feb; 11(1):26-32.
        View in: PubMed
      218. McAuley JD, Caglioti S, Williams RC, Robertson GF, Morgan L, Tobler LH, Busch MP. Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay. Transfusion. 2004 Jan; 44(1):91-6.
        View in: PubMed
      219. Delwart EL, Orton S, Parekh B, Dobbs T, Clark K, Busch MP. Two percent of HIV-positive U.S. blood donors are infected with non-subtype B strains. AIDS Res Hum Retroviruses. 2003 Dec; 19(12):1065-70.
        View in: PubMed
      220. Damesyn MA, Glynn SA, Schreiber GB, Ownby HE, Bethel J, Fridey J, McMullen Q, Garratty G, Busch MP. Behavioral and infectious disease risks in young blood donors: implications for recruitment. Transfusion. 2003 Nov; 43(11):1596-603.
        View in: PubMed
      221. Drew WL, Chou S, Mohr BA, Assmann SF, Miner RC, Laycock ME, Busch MP. Absence of activation of CMV by blood transfusion to HIV-infected, CMV-seropositive patients. Transfusion. 2003 Oct; 43(10):1351-7.
        View in: PubMed
      222. Tobler LH, Stramer SL, Lee SR, Masecar BL, Peterson JE, Davis EA, Andrews WE, Brodsky JP, Kleinman SH, Phelps BH, Busch MP. Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening. Transfusion. 2003 Oct; 43(10):1452-9.
        View in: PubMed
      223. Operskalski EA, Mosley JW, Tobler LH, Fiebig EW, Nowicki MJ, Mimms LT, Gallarda J, Phelps BH, Busch MP. HCV viral load in anti-HCV-reactive donors and infectivity for their recipients. Transfusion. 2003 Oct; 43(10):1433-41.
        View in: PubMed
      224. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003 Sep 5; 17(13):1871-9.
        View in: PubMed
      225. Murphy EL, Grant RM, Kropp J, Oliveira A, Lee TH, Busch MP. Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients. J Acquir Immune Defic Syndr. 2003 Aug 15; 33(5):655-6.
        View in: PubMed
      226. Busch MP, Tobler LH, Gerlich WH, Schaefer S, Giachetti C, Smith R. Very low level viremia in HCV infectious unit missed by NAT. Transfusion. 2003 Aug; 43(8):1173-4.
        View in: PubMed
      227. Rawal BD, Degula A, Lebedeva L, Janssen RS, Hecht FM, Sheppard HW, Busch MP. Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J Acquir Immune Defic Syndr. 2003 Jul 1; 33(3):349-55.
        View in: PubMed
      228. Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion. 2003 Jun; 43(6):696-704.
        View in: PubMed
      229. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion. 2003 Jun; 43(6):788-98.
        View in: PubMed
      230. Kral AH, Lorvick J, Gee L, Bacchetti P, Rawal B, Busch M, Edlin BR. Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998. Am J Epidemiol. 2003 May 15; 157(10):915-22.
        View in: PubMed
      231. Glynn SA, Busch MP, Schreiber GB, Murphy EL, Wright DJ, Tu Y, Kleinman SH. Effect of a national disaster on blood supply and safety: the September 11 experience. JAMA. 2003 May 7; 289(17):2246-53.
        View in: PubMed
      232. Alves K, Shafer KP, Caseiro M, Rutherford G, Falcao ME, Sucupira MC, Busch MP, Rawal BD, Diaz RS. Risk factors for incident HIV infection among anonymous HIV testing site clients in Santos, Brazil: 1996-1999. J Acquir Immune Defic Syndr. 2003 Apr 15; 32(5):551-9.
        View in: PubMed
      233. Asmuth DM, Kalish LA, Laycock ME, Murphy EL, Mohr BA, Lee TH, Gallarda J, Giachetti C, Dollard SC, van der Horst CM, Grant RM, Busch MP. Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection. Transfusion. 2003 Apr; 43(4):451-8.
        View in: PubMed
      234. Fang CT, Tobler LH, Haesche C, Busch MP, Phelps B, Leparc G. Fluctuation of HCV viral load before seroconversion in a healthy volunteer blood donor. Transfusion. 2003 Apr; 43(4):541-4.
        View in: PubMed
      235. Drew WL, Tegtmeier G, Alter HJ, Laycock ME, Miner RC, Busch MP. Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients. Transfusion. 2003 Mar; 43(3):309-13.
        View in: PubMed
      236. Roback JD, Drew WL, Laycock ME, Todd D, Hillyer CD, Busch MP. CMV DNA is rarely detected in healthy blood donors using validated PCR assays. Transfusion. 2003 Mar; 43(3):314-21.
        View in: PubMed
      237. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA. 2003 Feb 26; 289(8):959-62.
        View in: PubMed
      238. Sharma UK, Stramer SL, Wright DJ, Glynn SA, Hermansen S, Schreiber GB, Kleinman SH, Busch MP. Impact of changes in viral marker screening assays. Transfusion. 2003 Feb; 43(2):202-14.
        View in: PubMed
      239. Ariga H, Lee TH, Laycock ME, Mohr BA, Kalish LA, Yomtovian R, Gernsheimer T, Busch MP. Residual WBC subsets in filtered prestorage RBCs. Transfusion. 2003 Jan; 43(1):98-106.
        View in: PubMed
      240. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, Busch MP, Tobler LH, Phelps B, Moss AR. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis. 2002 Dec 1; 186(11):1558-64.
        View in: PubMed
      241. Turchi MD, Diaz RS, Martelli CM, Sabino EC, Da Silva WP, Filho OF, Laranjeira RR, Busch MP, Castelo A. Genetic diversity and HIV-1 incidence estimation among cocaine users in São Paulo, Brazil. J Acquir Immune Defic Syndr. 2002 Aug 15; 30(5):527-32.
        View in: PubMed
      242. Glynn SA, Kleinman SH, Wright DJ, Busch MP. International application of the incidence rate/window period model. Transfusion. 2002 Aug; 42(8):966-72.
        View in: PubMed
      243. Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, Petropoulos CJ, Hellmann NS, Chesney M, Busch MP, Kahn JO. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA. 2002 Jul 10; 288(2):181-8.
        View in: PubMed
      244. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS. 2002 May 24; 16(8):1119-29.
        View in: PubMed
      245. Drew WL, Chou S, Miner RC, Mohr BA, Busch MP, van der Horst CM, Asmuth DM, Kalish LA. Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis. J Infect Dis. 2002 Jul 1; 186(1):114-7.
        View in: PubMed
      246. Dodd RY, Busch MP. Animal models of bovine spongiform encephalopathy and vCJD infectivity in blood: two swallows do not a summer make. Transfusion. 2002 May; 42(5):509-12.
        View in: PubMed
      247. Weinstock H, Dale M, Gwinn M, Satten GA, Kothe D, Mei J, Royalty J, Linley L, Fridlund C, Parekh B, Rawal BD, Busch MP, Janssen RS. HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States. J Acquir Immune Defic Syndr. 2002 Apr 15; 29(5):478-83.
        View in: PubMed
      248. Schreiber GB, Glynn SA, Satten GA, Kong F, Wright D, Busch MP, Tu Y, Kleinman SH. HIV seroconverting donors delay their return: screening test implications. Transfusion. 2002 Apr; 42(4):414-21.
        View in: PubMed
      249. Machado DM, Delwart EL, Diaz RS, de Oliveira CF, Alves K, Rawal BD, Sullivan M, Gwinn M, Clark KA, Busch MP. Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors. AIDS. 2002 Jan 4; 16(1):113-9.
        View in: PubMed
      250. Lee TH, Wen L, Chrebtow V, Higuchi R, Watson RM, Sninsky JJ, Busch MP. Quantitation of residual WBCs in filtered blood components by high-throughput, real-time kinetic PCR. Transfusion. 2002 Jan; 42(1):87-93.
        View in: PubMed
      251. Chou SH, Chawla A, Lee TH, Zhou Y, Busch MP, Balassanian R, Ferrell L, Cowan MJ. Increased engraftment and GVHD after in utero transplantation of MHC-mismatched bone marrow cells and CD80low, CD86(-) dendritic cells in a fetal mouse model. Transplantation. 2001 Dec 15; 72(11):1768-76.
        View in: PubMed
      252. Busch MP. Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients. Transfus Clin Biol. 2001 Jun; 8(3):200-6.
        View in: PubMed
      253. Stranford SA, Ong JC, Martinez-Marino B, Busch M, Hecht FM, Kahn J, Levy JA. Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. Proc Natl Acad Sci U S A. 2001 Jan 16; 98(2):597-602.
        View in: PubMed
      254. Fiebig E, Hirschkorn DF, Maino VC, Grass JA, Lin L, Busch MP. Assessment of donor T-cell function in cellular blood components by the CD69 induction assay: effects of storage, gamma radiation, and photochemical treatment. Transfusion. 2000 Jul; 40(7):761-70.
        View in: PubMed
      255. Busch MP, Watanabe KK, Smith JW, Hermansen SW, Thomson RA. False-negative testing errors in routine viral marker screening of blood donors. For the Retrovirus Epidemiology Donor Study. Transfusion. 2000 May; 40(5):585-9.
        View in: PubMed
      256. Busch MP, Tobler LH, Tegtmeier G, Polito A, Quan S, Hirschler NV, Dockter J, Giachetti C, Mimms L. Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback. Transfusion. 2000 Jan; 40(1):10-4.
        View in: PubMed
      257. Tobler LH, Tegtmeier G, Stramer SL, Quan S, Dockter J, Giachetti C, Busch MP. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation. Transfusion. 2000 Jan; 40(1):15-24.
        View in: PubMed
      258. Busch MP. Comparative methods of viral gene amplification. Dev Biol (Basel). 2000; 102:69-80.
        View in: PubMed
      259. Busch M, Chamberland M, Epstein J, Kleinman S, Khabbaz R, Nemo G. Oversight and monitoring of blood safety in the United States. Vox Sang. 1999; 77(2):67-76.
        View in: PubMed
      260. Murphy EL, Busch MP, Tong M, Cornett P, Vyas GN. A prospective study of the risk of transfusion-acquired viral infections. Transfus Med. 1998 Sep; 8(3):173-8.
        View in: PubMed
      261. Busch MP, Dodd RY, Lackritz EM, AuBuchon JP, Birkmeyer JD, Petersen LR. Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group. Transfusion. 1997 Oct; 37(10):1003-11.
        View in: PubMed
      262. Busch MP, Glynn SA, Schreiber GB. Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob disease. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study. Transfusion. 1997 Oct; 37(10):996-1002.
        View in: PubMed
      263. Carrier E, Lee TH, Busch MP, Cowan MJ. Recruitment of engrafted donor cells postnatally into the blood with cytokines after in utero transplantation in mice. Transplantation. 1997 Aug 27; 64(4):627-33.
        View in: PubMed
      264. Busch MP, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med. 1997 May 19; 102(5B):117-24; discussion 125-6.
        View in: PubMed
      265. Adams MR, Johnson DK, Busch MP, Schembri CT, Hartz TP, Heaton WA. Automatic volumetric capillary cytometry for counting white cells in white cell-reduced plateletpheresis components. Transfusion. 1997 Jan; 37(1):29-37.
        View in: PubMed
      266. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med. 1996 Aug; 2(8):918-24.
        View in: PubMed
      267. Busch MP, Operskalski EA, Mosley JW, Lee TH, Henrard D, Herman S, Sachs DH, Harris M, Huang W, Stram DO. Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group. J Infect Dis. 1996 Jul; 174(1):26-33.
        View in: PubMed
      268. Carrier E, Lee TH, Busch MP, Cowan MJ. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells. Blood. 1995 Dec 15; 86(12):4681-90.
        View in: PubMed
      269. Goodarzi MO, Lee TH, Pallavicini MG, Donegan EA, Busch MP. Unusual kinetics of white cell clearance in transfused mice. Transfusion. 1995 Feb; 35(2):145-9.
        View in: PubMed
      270. Busch MP. Testing blood donors for HIV: current controversies. Immunol Invest. 1995 Jan-Feb; 24(1-2):147-54.
        View in: PubMed
      271. Busch MP, Operskalski EA, Mosley JW, Stevens CE, Schiff ER, Kleinman SH, Lee H, Lee M, Harris M. Epidemiologic background and long-term course of disease in human immunodeficiency virus type 1-infected blood donors identified before routine laboratory screening. Transfusion Safety Study Group. Transfusion. 1994 Oct; 34(10):858-64.
        View in: PubMed
      272. Sankary TM, Yang G, Romeo JM, Ulrich PP, Busch MP, Rawal BD, Vyas GN. Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase. Transfusion. 1994 Aug; 34(8):656-60.
        View in: PubMed
      273. Donegan E, Lee H, Operskalski EA, Shaw GM, Kleinman SH, Busch MP, Stevens CE, Schiff ER, Nowicki MJ, Hollingsworth CG, et al. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion. 1994 Jun; 34(6):478-83.
        View in: PubMed
      274. Tobler LH, Busch MP, Wilber J, Dinello R, Quan S, Polito A, Kochesky R, Bahl C, Nelles M, Lee SR. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors. Transfusion. 1994 Feb; 34(2):130-4.
        View in: PubMed
      275. Samson SM, Edmiston RK, Busch MP, Perkins HA. Declining efficacy of AIDS case list cross-referencing in human immunodeficiency virus look-back: 1981 through 1992. Transfusion. 1994 Feb; 34(2):147-51.
        View in: PubMed
      276. Busch MP. HIV and blood transfusions: focus on seroconversion. Vox Sang. 1994; 67 Suppl 3:13-8.
        View in: PubMed
      277. Tappero JW, Koehler JE, Berger TG, Cockerell CJ, Lee TH, Busch MP, Stites DP, Mohle-Boetani J, Reingold AL, LeBoit PE. Bacillary angiomatosis and bacillary splenitis in immunocompetent adults. Ann Intern Med. 1993 Mar 1; 118(5):363-5.
        View in: PubMed
      278. Romeo JM, Ulrich PP, Busch MP, Vyas GN. Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donors. Hepatology. 1993 Feb; 17(2):188-95.
        View in: PubMed
      279. Busch MP, Tobler L, Quan S, Wilber JC, Johnson P, Polito A, Steane E, Zola A, Bahl C, Nelles M, et al. A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors. Transfusion. 1993 Jan; 33(1):84-8.
        View in: PubMed
      280. Eble BE, Busch MP, Khayam-Bashi H, Nason MA, Samson S, Vyas GN. Resolution of infection status of human immunodeficiency virus (HIV)-seroindeterminate donors and high-risk seronegative individuals with polymerase chain reaction and virus culture: absence of persistent silent HIV type 1 infection in a high-prevalence area. Transfusion. 1992 Jul-Aug; 32(6):503-8.
        View in: PubMed
      281. Busch MP, Henrard DR, Hewlett IK, Mehaffey WF, Epstein JS, Allain JP, Lee TH, Mosley JW. Poor sensitivity, specificity, and reproducibility of detection of HIV-1 DNA in serum by polymerase chain reaction. The Transfusion Safety Study Group. J Acquir Immune Defic Syndr. 1992; 5(9):872-7.
        View in: PubMed
      282. Busch MP, Guiltinan A, Skettino S, Cordell R, Zeger G, Kleinman S. Safety of blood donations following a natural disaster. Transfusion. 1991 Oct; 31(8):719-23.
        View in: PubMed
      283. Busch MP, Eble BE, Khayam-Bashi H, Heilbron D, Murphy EL, Kwok S, Sninsky J, Perkins HA, Vyas GN. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N Engl J Med. 1991 Jul 4; 325(1):1-5.
        View in: PubMed
      284. Busch MP, el Amad Z, McHugh TM, Chien D, Polito AJ. Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay. Transfusion. 1991 Feb; 31(2):129-37.
        View in: PubMed
      285. Brown M, Reed S, Levy JA, Busch M, McKerrow JH. Detection of HIV-1 in Entamoeba histolytica without evidence of transmission to human cells. AIDS. 1991 Jan; 5(1):93-6.
        View in: PubMed
      286. Rawal B, Yen TS, Vyas GN, Busch M. Leukocyte filtration removes infectious particulate debris but not free virus derived from experimentally lysed HIV-infected cells. Vox Sang. 1991; 60(4):214-8.
        View in: PubMed
      287. Rawal BD, Schwadron R, Busch MP, Endow R, Vyas GN. Evaluation of leukocyte removal filters modelled by use of HIV-infected cells and DNA amplification. Blood. 1990 Nov 15; 76(10):2159-61.
        View in: PubMed
      288. Rawal BD, Davis RE, Busch MP, Vyas GN. Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collection. Transfus Med Rev. 1990 Oct; 4(4 Suppl 1):36-41.
        View in: PubMed
      289. Donegan E, Busch MP, Galleshaw JA, Shaw GM, Mosley JW. Transfusion of blood components from a donor with human T-lymphotropic virus type II (HTLV-II) infection. The Transfusion Safety Study Group. Ann Intern Med. 1990 Oct 1; 113(7):555-6.
        View in: PubMed
      290. Roy S, Morrow WJ, Christian C, Khayam-Bashi H, Busch MP, McCarthy R, Rodgers RP, Vyas GN. Persistent immune complexes and abnormal CD4/CD8 ratios in HIV infection. J Acquir Immune Defic Syndr. 1990; 3(2):134-8.
        View in: PubMed
      291. Hjelle B, Busch M. Direct methods for detection of HIV-1 infection. Arch Pathol Lab Med. 1989 Sep; 113(9):975-80.
        View in: PubMed
      292. Scillian JJ, McHugh TM, Busch MP, Tam M, Fulwyler MJ, Chien DY, Vyas GN. Early detection of antibodies against rDNA-produced HIV proteins with a flow cytometric assay. Blood. 1989 May 15; 73(7):2041-8.
        View in: PubMed
      293. McHugh TM, Stites DP, Busch MP, Krowka JF, Stricker RB, Hollander H. Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24, and HIV-containing immune complexes in HIV-infected patients. J Infect Dis. 1988 Nov; 158(5):1088-91.
        View in: PubMed
      294. Calman AF, Busch MP, Vyas GN, McHugh TM, Stites DP, Peterlin BM. Transcription and replication of human immunodeficiency virus-1 in B lymphocytes in vitro. AIDS. 1988 Jun; 2(3):185-93.
        View in: PubMed
      295. Krowka J, Stites D, Mills J, Hollander H, McHugh T, Busch M, Wilhelm L, Blackwood L. Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus. Clin Exp Immunol. 1988 May; 72(2):179-85.
        View in: PubMed
      296. Ulrich PP, Busch MP, el-Beik T, Shiota J, Vennari J, Shriver K, Vyas GN. Assessment of human immunodeficiency virus expression in cocultures of peripheral blood mononuclear cells from healthy seropositive subjects. J Med Virol. 1988 May; 25(1):1-10.
        View in: PubMed
      297. Busch MP, Rajagopalan MS, Gantz DM, Fu S, Steimer KS, Vyas GN. In situ hybridization and immunocytochemistry for improved assessment of human immunodeficiency virus cultures. Am J Clin Pathol. 1987 Dec; 88(6):673-80.
        View in: PubMed
      Michael's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP